The Valley Desk

NCT06839976 · Interventional trial

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions CAR T Cell, CART19, Cell Therapy, Lupus, Lupus Nephritis (LN), SLE, Systemic Lupus Erythematosus (SLE)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov